Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Items 401–500 of 1,000
Rozmus, J., Schultz, K. R., Wynne, K., Kariminia, A., Satyanarayana, P., Krailo, M., Grupp, S. A., Gilman, A. L., & Goldman, F. D. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.05.011 · Cited by 45
“We now know that Foxp3 expression is not uniquely associated with regulatory T cells [51,52].”
BackgroundZhong, Y., Tang, H., Wang, X., Zeng, Q., Liu, Y., Zhao, X., Yu, K., Shi, H., Zhu, R., & Mao, X. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12726 · Cited by 43
Yip, W. K., Abdullah, M. A., Yusoff, S. M., & Seow, H. F. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03793.x · Cited by 42
Lehé, C. L., Ghebeh, H., Al-Sulaiman, A., Qudaihi, G. A., Al‐Hussein, K., Almohareb, F. I., Chaudhri, N. A., Alsharif, F. Z., Alzahrani, H. A., Tbakhi, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0050 · Cited by 44
“Foxp3 is also expressed transiently in activated non-Tregs ( 26 ).”
CD30 Discriminates Heat Shock Protein 60-Induced FOXP3+CD4+ T Cells with a Regulatory Phenotype
de Kleer, I., Vercoulen, Y., Klein, M., Meerding, J., Albani, S., van der Zee, R., Sawitzki, B., Hamann, A., Kuis, W., & Prakken, B. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901901 · Cited by 43
Rodríguez‐Pinto, D., Navas, A., Blanco, V. M., Ramírez, L. G., Garcerant, D., Cruz, A. R., Craft, N. A., & Saravia, N. G. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001627 · Cited by 42
“Alternatively, the higher proportion of CD25Foxp3 cells may reflect chronic activation in CDL patients, since FoxP3 can be transiently expressed by activated T cells [49,50].”
BackgroundT regulatory cells, the evolution of targeted immunotherapy
Nizar, S. A., Meyer, B., Galustian, C., Kumar, D., & Dalgleish, A. G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.02.001 · Cited by 50
Role of microRNAs in HTLV-1 infection and transformation
Ruggero, K., Corradin, A., Zanovello, P., Amadori, A., Bronte, V., Ciminale, V., & D’Agostino, D. M. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.05.001 · Cited by 41
Moraes‐Vieira, P. M., Silva, H. M., Takenaka, M. C., Monteiro, S. M., Lemos, F. B. C., Saitovitch, D., Kalil, J. E., & Coelho, V. P. C. V. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.01.022 · Cited by 42
Fourcade, J. J., Sun, Z., Kudela, P., Janjic, B. M., Kirkwood, J. M., El-Hafnawy, T., & Zarour, H. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903612 · Cited by 40
Freiser, M. E., Serafini, P., & Weed, D. T. (2013) · Immunologic Research · doi:10.1007/s12026-013-8462-3 · Cited by 42
“Indeed, FOXP3 can be expressed also by non-regulatory, activated effector T cells [78].”
BackgroundAnaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium
Busch, C., Annamalai, B., Abdusalamova, K., Reichhart, N., Huber, C., Lin, Y., Jo, E. A. H., Zipfel, P. F., Skerka, C., Wildner, G., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00703 · Cited by 43
“Nevertheless, some remaining T-cells were still detected in the retina (Figure S2B in Supplementary Material), which did not express FoxP3, suggesting that they were neither activated nor regulatory T-cells.”
InfluentialMiao, J., & Zhu, P. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0729-1 · Cited by 39
The tumour immune landscape and its implications in cutaneous melanoma
Attrill, G. H., Ferguson, P. M., Palendira, U., Long, G. V., Wilmott, J. S., & Scolyer, R. A. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12926 · Cited by 45
“However, as well as being used to identify Tregs, the transcription factor FoxP3 can also be expressed by activated helper CD4+ T cells (Wang et al., 2007).”
BackgroundCiccocioppo, R., Russo, M. L., Bernardo, M. E., Biagi, F., Catenacci, L., Avanzini, M. A., Alvisi, C., Vanoli, A., Manca, R., Luinetti, O., et al. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.04.014 · Cited by 40
“Moreover, we cannot rule out that these cells are effectory T cells because the main markers for the identification of regulatory T cells, CD25 and FoxP3, are also expressed by activated T cells and can be altered in inflammatory conditions.(17) Remarkably, MSCs also modulate B-cell function, leading to inhibition of…”
BackgroundIntragraft Levels of Foxp3 mRNA Predict Progression in Renal Transplants with Borderline Change
Mansour, H., Homs, S., Desvaux, D., Badoual, C., Dahan, K., Matignon, M., Audard, V., Lang, P., & Grimbert, P. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030254 · Cited by 40
Role of regulatory T-cells in autoimmunity
Mellanby, R. J., Thomas, D., & Lamb, J. R. (2009) · Clinical Science · doi:10.1042/cs20080200 · Cited by 50
The regulatory T cells in anti-influenza antibody response post influenza vaccination
Wang, S.-M., Tsai, M.-H., Lei, H.-Y., Wang, J., & Liu, C. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21117 · Cited by 39
Self-citationAn, B., Liu, X., Li, G., & Yuan, H. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000476 · Cited by 38
The Immune System's Contribution to the Clinical Efficacy of EGFR Antagonist Treatment
Macdonald, F., & Zaiss, D. M. W. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00575 · Cited by 41
“These cell types include macrophages (Scholes, 2001; Lanaya et al., 2014), monocytes (Chan et al., 2009), plasma cells (Mahtouk et al., 2005), and certain T cell subsets such as effector CD4 T cells and FoxP3-expressing regulatory CD4 T cells (Tregs) (Zaiss et al., 2013).”
BackgroundInfluentialShimabukuro‐Vornhagen, A., Zoghi, S., Liebig, T. M., Wennhold, K., Chemitz, J., Draube, A., Kochanek, M., Blaschke, F., Pallasch, C. P., Holtick, U., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1203436 · Cited by 40
“FOXP3 is generally considered to be a marker for regulatory T cells but can also be transiently expressed in activated but hyporesponsive effector T cells (66).”
BackgroundRegulatory T cell therapy as individualized medicine for asthma and allergy
Xystrakis, E., Urry, Z., & Hawrylowicz, C. M. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f14d7c · Cited by 41
Holcar, M., Goropevšek, A., Ihan, A., & Avčin, T. (2015) · Journal of Immunology Research · doi:10.1155/2015/352934 · Cited by 46
“The latter process could explain the decline in the amount of circulating Tregs, which has been observed in patients with atopic allergies, food allergies, chronic graft-versus-host disease, and, in particular, various systemic autoimmune diseases such as primary antiphospholipid syndrome, rheumatoid arthritis, and sy…”
Lee, J., Park, N., Park, J. Y., Kaplan, B. L. F., Pruett, S. B., Park, J. W., Park, Y. H., & Seo, K. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602109 · Cited by 40
“Although FOXP3 has an essential role in the development of Tregs, as demonstrated in this study and others, it may not be a reliable marker for Tregs, especially in humans, because T cell activation via TCR transiently induces expression of FOXP3 in CD4 and CD8 T cells (37, 38).”
BackgroundRegulatory Cells and Transplantation Tolerance
Cobbold, S. P., & Waldmann, H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015545 · Cited by 42
Pillai, V., & Karandikar, N. J. (2008) · Blood · doi:10.1182/blood-2007-09-111823 · Cited by 38
Adult T Cell Leukemia/Lymphoma: FoxP3+ Cells and the Cell-Mediated Immune Response to HTLV-1
Bangham, C. R. M., & Toulza, F. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-385524-4.00004-0 · Cited by 40
“Perhaps FoxP3 expression in these cells is caused by Tax protein-induced T-cell activation (Allan et al., 2007; Wang et al., 2007).”
BackgroundXiao, J., Liu, C., Li, G., Peng, S., Hu, J. N., Qu, L., Lv, P., Zhang, Y., Ma, D., & Chen, Y. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.08.002 · Cited by 38
“However, activated T cells in which FOXP3 expression is maintained at a high and stable level can become immunosuppressive [53].”
BackgroundKorten, S., Badusche, M., Büttner, D. W., Hoerauf, A. M., Brattig, N. W., & Fleischer, B. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.12.004 · Cited by 37
Rissetto, K., Rindt, H., Selting, K. A., Villamil, J. A., Henry, C. J., & Reinero, C. R. (2010) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2010.02.002 · Cited by 41
Rech, A. J., Mick, R., Kaplan, D. E., Chang, K., Domchek, S. M., & Vonderheide, R. H. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0780-x · Cited by 44
Bastien, J.-P., Krosl, G., Thérien, C., Rashkovan, M., Scotto, C., Cohen, S., Allan, D., Hogge, D. E., Egeler, R. M., Perreault, C., et al. (2010) · Blood · doi:10.1182/blood-2010-03-273193 · Cited by 41
Low-Dose Antigen Promotes Induction of FOXP3 in Human CD4+ T Cells
Long, S. A., Rieck, M., Tatum, M., Bollyky, P. L., Wu, R. P., Muller, I., Ho, J.-C., Shilling, H. G., & Buckner, J. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003880 · Cited by 49
“tion, and a lack of suppression was observed (51, 57, 58).”
BackgroundBarberis, M., Helikar, T., & Verbruggen, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00879 · Cited by 38
“Activated T cells can transiently upregulate FOXP3 levels (Gavin et al., 2006), and activated T cells carrying high and stable expression levels of FOXP3 can become immunosuppressive (Wang et al., 2007).”
BackgroundHope, C. M., Welch, J., Mohandas, A. P., Pederson, S., Hill, D. L., Gundsambuu, B., Eastaff‐Leung, N., Grosse, R., Bresatz, S., Ang, G., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201948094 · Cited by 39
Regulatory T cells: the future of autoimmune disease treatment
Ryba-Stanisławowska, M. E., Sakowska, J., Zieliński, M., Ławrynowicz, U., & Trzonkowski, P. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1620602 · Cited by 39
Cabral-Marques, O., Schimke, L. F., de Oliveira, E. B., Khawanky, N. E., Ramos, R. N., al-Ramadi, B. K., Segundo, G. R. S., Ochs, H. D., & Condino‐Neto, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02742 · Cited by 43
Kim, H.-R., Lee, A., Choi, E.-J., Kie, J. H., Lim, W., Lee, H. K., Moon, B.-I., & Seoh, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095332 · Cited by 37
“At present, FoxP3 is the most specific to Tregs, but it is not also absolutely specific [35,36].”
BackgroundBoer, M. C., van Meijgaarden, K. E., Joosten, S. A., & Ottenhoff, T. H. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094192 · Cited by 37
“However, also nonsuppressive, activated human CD4 T cells may transiently upregulate Foxp3-expression such that in vitro-induced Foxp3 expression by human CD4 T cells is not necessarily associated with suppressive function [36].”
BackgroundPotential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood
Hua, F., Kang, N., Gao, Y., Cui, L., Ba, D., & He, W. (2013) · Immunologic Research · doi:10.1007/s12026-013-8390-2 · Cited by 37
Backteman, K., Andersson, C., Dahlin, L.-G., Ernerudh, J., & Jonasson, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032691 · Cited by 37
“A transient expression of Foxp3 in human CD25(2)CD4 T cells has been shown after in vitro stimulation, although without the gain of suppressive function [28].”
BackgroundMatthews, K., Lim, Z. Z., Afzali, B., Pearce, L., Abdallah, A. M., Kordasti, S. Y., Pagliuca, A., Lombardi, G., Madrigal, J. A., Mufti, G. J., et al. (2009) · Haematologica · doi:10.3324/haematol.2008.003103 · Cited by 37
“05 (7-89) (1-110) CD4 central memory 4 1 0.”
der Lee, A. J., Rutten, V. P. M. G., Bruijn, J., Willemse, T., & Broere, F. (2014) · Veterinary Dermatology · doi:10.1111/vde.12140 · Cited by 47
Tateosian, N. L., Reiteri, R. M., Amiano, N. O., Costa, M. J., Villalonga, X., Guerrieri, D., & Maffía, P. C. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.03.013 · Cited by 39
Mahic, M., Yaqub, S., Bryn, T., Henjum, K., Eide, D. M., Torgersen, K. M., Aandahl, E. M., & Taskén, K. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507329 · Cited by 37
“This is in line with recent publications that demonstrate a transient induction of TR cells upon activation of CD4 CD25– T cells [11, 13, 14].”
ResultRethinking the molecular definition of regulatory T cells
Hori, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838147 · Cited by 37
Epigenetic biomarkers of T-cells in human glioma
Wiencke, J. K., Accomando, W. P., Zheng, S., Patoka, J., Dou, X., Phillips, J. J., Hsuang, G., Christensen, B. C., Houseman, E. A., Koestler, D. C., et al. (2012) · Epigenetics · doi:10.4161/epi.22675 · Cited by 37
Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond
Christophersen, A. O., Risnes, L. F., Dahal‐Koirala, S., & Sollid, L. M. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.009 · Cited by 43
Human CD4+CD25highCD127low/neg Regulatory T Cells
Su, H., Longhi, M. S., Wang, P., Mieli‐Vergani, G., & Ma, Y. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-367-7_20 · Cited by 36
Lu, C., Wu, C.-J., Chan, C.-C., Nguyen, D. T., Lin, K.-R., Lin, S., Chen, L., Yen, J. J.-Y., & Kuo, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00488 · Cited by 36
“Activation of human CD4+CD25− T cells through TCR stimulation results in transient, low level expression of FOXP3 without conferring suppressive activity (6, 7), indicating that FOXP3 must be constitutively expressed to maintain Treg cell function.”
BackgroundPinheiro, D., Chang, Y., Bryant, H., Szladovits, B., Dalessandri, T., Davison, L. J., Yallop, E., Mills, E., Leo, C., Lara‐Garcia, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105027 · Cited by 42
“While a large number of markers for Tregs have been proposed, FOXP3 remains the single most widely applied phenotypic credential of regulatory activity in cancer and other studies [96–98], despite being transiently expressed in activated human and canine conventional T cells lacking regulatory function [46,99].”
BackgroundXing, S., Fu, J., Zhang, Z., Gao, Y., Jiao, Y., Kang, F., Zhang, J., Zhou, C., Wu, H., & Wang, F. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e453b9 · Cited by 35
Harris, R. C., Chianese‐Bullock, K. A., Petroni, G. R., Schaefer, J. T., Brill, L. B., Molhoek, K. R., Deacon, D. H., Patterson, J. W., & Slingluff, C. L. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31823731a4 · Cited by 36
de Paz, B., Prado, C., Alpéri, M., Ballina‐García, F. J., Rodríguez‐Carrio, J., López, P., & Suárez, A. (2012) · Rheumatology · doi:10.1093/rheumatology/kes039 · Cited by 37
CD4+T Cell Fate in Glomerulonephritis: A Tale of Th1, Th17, and Novel Treg Subtypes
Krebs, C. F., & Steinmetz, O. M. (2016) · Mediators of Inflammation · doi:10.1155/2016/5393894 · Cited by 36
Characterization of CD4+ FOXP3+ T‐cell clones established from chronic inflammatory lesions
Okui, T., Ito, H., Honda, T., Amanuma, R., Yoshie, H., & Yamazaki, K. (2007) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2007.00390.x · Cited by 36
Chronic reactive gliosis following regulatory T cell depletion during acute MCMV encephalitis
Lokensgard, J. R., Schachtele, S. J., Mutnal, M. B., Sheng, W. S., Prasad, S., & Hu, S. (2015) · Glia · doi:10.1002/glia.22868 · Cited by 35
“In humans, but not mice, Foxp3 has also been reported to be expressed in CD41 T-cells which were found to be hyporesponsive, but not necessarily suppressive (Morgan et al., 2005; Tran et al., 2007; Wang et al., 2007).”
BackgroundHemelen, D. V., Elberink, J. N. G. O., Heimweg, J., van Oosterhout, A. J. M., & Nawijn, M. C. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.11.012 · Cited by 35
“, 2006), but are not specific for this subset of CD4 T cells, as recently activated T cells are also able to transiently express CD25 and FoxP3 (Wang et al., 2007).”
BackgroundSmith, K. A., & Popmihajlov, Z. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00654.x · Cited by 35
“Very recently, others (76) reported similar findings, while still others reported that antibodies reactive with IL-2 or the IL-2R diminished TCR/CD3-induced FOXP3 expression by CD8(1) T cells (78).”
BackgroundResultWu, K., Bi, Y., Sun, K., Xia, J., Wang, Y., & Wang, C. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.02050.x · Cited by 36
Leal, F. E., Ndhlovu, L. C., Hasenkrug, A. M., Bruno, F. R., Carvalho, K. I., Wynn-Williams, H., Neto, W. K., Sanabani, S. S., Segurado, A. A. C., Nixon, D. F., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002028 · Cited by 41
“Activated CD4 T cells may also express most markers used to define Treg including FoxP3, the forkhead transcription factor [76].”
BackgroundRachayon, M., Jirakran, K., Sodsai, P., Sughondhabirom, A., & Maes, M. H. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-61865-y · Cited by 42
Regulatory T cell response correlates with the severity of human hantavirus infection
Koivula, T.-T., Tuulasvaara, A., Hetemäki, I., Mäkelä, S., Mustonen, J. T., Sironen, T. A., Vaheri, A. I., & Arstila, T. P. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.11.007 · Cited by 34
FOXP3 Subcellular Localization Predicts Recurrence in Oral Squamous Cell Carcinoma
Weed, D. T., Walker, G. R., Fuente, A. C. D. L., Nazarian, R., Vella, J. L., Gomez-Fernandez, C. R., & Serafini, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071908 · Cited by 34
“In this case, FOXP3 expression is not indicative of a regulatory function but, instead, of either incompletely activated effector cells [11] or activated memory effector T cells [12].”
BackgroundCytokines, chemokine receptors, CD4+CD25HIGH+ T-cells and clinical forms of human schistosomiasis
Teixeira‐Carvalho, A., Martins‐Filho, O. A., Peruhype-Magalhães, V., Silveira-Lemos, D., Malaquias, L. C. C., Oliveira, L. F. A., Silveira, A. M. S., Gazzinelli, A., Gazzinelli, G., & Corrêa‐Oliveira, R. (2008) · Acta Tropica · doi:10.1016/j.actatropica.2008.04.010 · Cited by 34
Lipscomb, M. W., Chen, L., Taylor, J. L., Goldbach, C., Watkins, S. C., Kaliński, P., Butterfield, L. H., Wesa, A. K., & Storkus, W. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901477 · Cited by 35
Nedoszytko, B., Lange, M., Sokołowska‐Wojdyło, M., Renke, J., Trzonkowski, P., Sobjanek, M., Szczerkowska‐Dobosz, A., Niedoszytko, M., Górska, A., Romantowski, J., et al. (2017) · Advances in Dermatology and Allergology · doi:10.5114/ada.2017.69305 · Cited by 36
T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus
Loza, M. J., Anderson, A. S., O’Rourke, K. S., Wood, J., & Khan, I. U. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.06.010 · Cited by 41
Bowen, L., Riva, F., Mohr, C., Aldridge, B. M., Schwartz, J., Miles, A. K., & Stott, J. L. (2007) · EcoHealth · doi:10.1007/s10393-007-0113-5 · Cited by 34
CD4+CD25+ but not CD4+Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis
Wang, D., Zhang, H., Liang, J., Gu, Z., Zhou, Q., Fan, X., Hou, Y., & Sun, L. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.40 · Cited by 37
“25 and used for many years in identifying Tregs, current studies have found that overactivated CDp T cells can also transiently express Foxp3, and these Foxpp T cells have no immunosuppressive activity”
BackgroundGiles, E. M., Sanders, T. J., McCarthy, N. E., Lung, J., Pathak, M., MacDonald, T. T., Lindsay, J., & Stagg, A. J. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.44 · Cited by 35
Joosse, M. E., Menckeberg, C. L., de Ruiter, L. F., Raatgeep, H. C., van Berkel, L. A., Simons-Oosterhuis, Y., Tindemans, I., Muskens, A. M., Hendriks, R. W., Hoogenboezem, R. M., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0078-4 · Cited by 38
Regulatory T cells in primary immunodeficiency diseases
Torgerson, T. R., & Ochs, H. D. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f1a27a · Cited by 34
Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity
Nirmala, S. S., Kayani, K., Gliwiński, M., Hu, Y., Iwaszkiewicz‐Grześ, D., Piotrowska, M., Sakowska, J., Tomaszewicz, M., Morales, J. M. M., Lakshmi, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1321228 · Cited by 45
Westerholm‐Ormio, M., Vaarala, O., Tiittanen, M., & Savilahti, E. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181cd2636 · Cited by 33
“CD25 is also expressed on activated effector T cells, and Foxp3 is transiently expressed on effector T cells during activation (33).”
BackgroundVercoulen, Y., Wehrens, E. J., van Teijlingen, N. H., de Jager, W., Beekman, J. M., & Prakken, B. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007183 · Cited by 37
“Pivotal studies in mice models have pointed out that Treg are indispensable for the maintenance of peripheral immune tolerance. Also in humans a similar role of Tregs is likely, prompting discussions about their clinical applicability. Though comparable in many aspects, several differences between mouse and human Treg…”
BackgroundPagliarulo, F., Cheng, P. F., Brugger, L., van Dijk, N., Heijden, M. S. V. D., Levesque, M. P., Siliņa, K., & van den Broek, M. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.793992 · Cited by 39
“Human FOXP3 is transiently induced in response to TCR engagement of effector T cells (65); thus, the increased FOXP3 expression here may signify increased infiltration of activated effector T cells rather than T regulatory cells.”
BackgroundHeat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?
Vercoulen, Y., van Teijlingen, N. H., de Kleer, I. M., Kamphuis, S., Albani, S., & Prakken, B. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2674 · Cited by 33
Moreira, G., Fulgêncio, L. B., Mendonça, E. F., Leles, C. R., Batista, A. C., & Silva, T. A. (2009) · Oncology Letters · doi:10.3892/ol_00000023 · Cited by 36
“The expression of FoxP3 can be transiently induced in human non-Treg cells by activation through the T-cell receptor (28,29).”
Xu, W., Ren, M., Ghosh, S., Qian, K., Luo, Z., Zhang, A., Zhang, C., & Cui, J. (2020) · Mediators of Inflammation · doi:10.1155/2020/3645157 · Cited by 32
Lü, C.-X., Xu, R., Cao, M., Wang, G., Yan, F., Shang, S.-S., Wu, X.-F., Ruan, L., Quan, X., & Zhang, C. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.007 · Cited by 32
Whole genome methylation array reveals the down-regulation of IGFBP6 and SATB2 by HIV-1
Zhang, Y., Li, S.-K., Yang, Y., Liu, M., Lee, N. L. S., Tang, X., Wang, H., Liu, L., Chen, Z., Zhang, C., et al. (2015) · Scientific Reports · doi:10.1038/srep10806 · Cited by 36
Self-citationElizondo, D. M., Andargie, T. E., Yang, D., Kacsinta, A. D., & Lipscomb, M. W. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01502 · Cited by 34
“During these investigations, evaluating CD25 and Foxp3 12–14 days after primary stimulation with siAIF1 or control DC ensured that expression was not a transient byproduct of initial T cell activation (31).”
MethodPerga, S., Martire, S., Montarolo, F., Giordani, I., Spadaro, M., Bono, G., Corvisieri, S., Messuti, I., Panzica, G., Orlandi, F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00311 · Cited by 37
“However, it is also highly expressed by the recently activated conventional human T cells (76, 77).”
BackgroundMicroenvironment tailors nTreg structure and function
Schiavon, V., Duchez, S., Branchtein, M., How‐Kit, A., Cassius, C., Daunay, A., Shen, Y., Dubanchet, S., Colisson, R., Vanneaux, V., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812471116 · Cited by 32
Janssens, I., & Cools, N. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104236 · Cited by 37
Regulatory T cells in ankylosing spondylitis and the response after adalimumab treatment
Liao, H., Lin, Y., Tsai, C., & Chou, C. (2015) · Joint Bone Spine · doi:10.1016/j.jbspin.2015.03.003 · Cited by 32
Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer
Chaudhary, B., Samid, M. A. A., al-Ramadi, B. K., & Elkord, E. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.900539 · Cited by 35
“Indeed activated FoxP3 non-Tregs have been reported to secrete the effector cytokines IL-2, IFN-g and TNF-a [45].”
BackgroundInfluentialPetrausch, U., Poehlein, C. H., Jensen, S. M., Twitty, C., Thompson, J., Assmann, I., Puri, S., LaCelle, M. G., Moudgil, T. L., Maston, L. D., et al. (2009) · Current Molecular Medicine · doi:10.2174/156652409788970670 · Cited by 31
CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer
Lam, J. H., Hong, M., Koo, S.-L., Chua, C. W. L., Lim, K. L., Wee, F., Wan, W. K., Leow, W. Q., Yeo, J. G., Tan, I. B. H., et al. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-021-02859-x · Cited by 31
Curcumin in Inflammatory Complications: Therapeutic Applications and Clinical Evidence
Zafar, A., Lahori, D., Namit, A. F., Paxton, Z., Ratna, N., Thornton, D., & Ramana, K. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199366 · Cited by 45
“Furthermore, mice treated with curcumin exhibited increased levels of CD4+ and CD25+ regulatory T cells (Tregs) and the interleukin-10 (IL-10) cytokine [156].”
Landskron, J., & Taskén, K. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.04.008 · Cited by 31
Strömbeck, A., Rabe, H., Lundell, A., Andersson, K., Johansen, S., Adlerberth, I., Wold, A. E., Hesselmar, B., & Rudin, A. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12290 · Cited by 34
Axelsson, S., Hjorth, M., Åkerman, L., Ludvigsson, J., & Casas, R. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1126 · Cited by 31
“Although FOXP3 expression has been shown to be upregulated after in vitro activation of non-regulatory CD4+ T cells [35,36], it is at present the best marker for Tregs.”
BackgroundBjörkander, S., Hell, L., Johansson, M. A., Forsberg, M. M., Lasaviciute, G., Roos, S., Holmlund, U., & Sverremark‐Ekström, E. (2016) · Scientific Reports · doi:10.1038/srep22083 · Cited by 36
Regulatory T cells in lung transplantation—an emerging concept
Neujahr, D. C., & Larsen, C. P. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0253-0 · Cited by 31
“In particular, footpad swelling was not dependent on either CD8 cells or INFγ, but was dependent of CD4 cells capable of producing IL-17 and CD14+ monocytes capable of producing IL-1β and TNF-α.”
InfluentialFlow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells
Crellin, N. K., García, R., & Levings, M. K. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.05.008 · Cited by 31
Schnell, A., Schmidl, C., Herr, W., & Siska, P. J. (2018) · Biomedicines · doi:10.3390/biomedicines6010025 · Cited by 36
“However, as opposed to murine T cells, FOXP3 is expressed in human T cells that are both immunosuppressive and inflammatory [97,98].”
BackgroundOyarce, K., Campos‐Mora, M., Gajardo, T., & Pino‐Lagos, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00112 · Cited by 30
“This CD4+ Foxp3/GFPint T cell population could correspond to a transient Foxp3 expression in non-Treg cells, which has been reported in other studies (54, 55), meaning that VitC abrogates this process, favoring Treg generation with high levels of Foxp3.”
ResultTranscriptional regulation of Treg homeostasis and functional specification
Wang, K., & Fu, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03534-7 · Cited by 37
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.